PCNA and endometrial cancer: Inhibited proliferation, downregulated estrogen receptor α, progesterone receptor, proliferating cell nuclear antigen, and cyclin D1, increased apoptosis, upregulated Bax, downregulated Bcl2, and induced ROS and oxidative stress in endometrial cancer cells